Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients (Q36689257)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 January 2013
edit
Language Label Description Also known as
English
Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients
scientific article published on 11 January 2013

    Statements

    Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients (English)
    Heather Macdonald
    Sherfaraz K Patel
    Colleen Azen
    Frank Z Stanczyk
    Nigel Clarke
    11 January 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit